UC San Diego receives FDA approval for trial of ABSA01 therapy

UC San Diego receives FDA approval for trial of AB-SA01 therapy

19:00 EST 9 Jan 2019 | Net Resources International

A team of physician-scientists at University of California San Diego School of Medicine (UC San Diego) has received approval from...
Read More...

The post UC San Diego receives FDA approval for trial of AB-SA01 therapy appeared first on Drug Development Technology.

Original Article: UC San Diego receives FDA approval for trial of AB-SA01 therapy

More From BioPortfolio on "UC San Diego receives FDA approval for trial of AB-SA01 therapy"